Skip to main content

Advertisement

Log in

ASO Visual Abstract: Interferon Alpha-Expressing Oncolytic Adenovirus for the Treatment of Esophageal Adenocarcinoma

  • ASO Visual Abstract
  • Published:
Annals of Surgical Oncology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Funding

The project is partly supported by NIH/NCI R01CA228760-01A1 (MY/JD) and a University of Minnesota-VFW Surgical Oncology Research Award (C.J.L.).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Christopher J. LaRocca MD.

Ethics declarations

Disclosure

The authors declare that they have no conflict of interest.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

LaRocca, C.J., Salzwedel, A.O., Sato-Dahlman, M. et al. ASO Visual Abstract: Interferon Alpha-Expressing Oncolytic Adenovirus for the Treatment of Esophageal Adenocarcinoma. Ann Surg Oncol 28 (Suppl 3), 565–566 (2021). https://doi.org/10.1245/s10434-021-10422-2

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1245/s10434-021-10422-2

Navigation